Five-year outcomes from the randomized, phase 3 trials CheckMate 017/057: nivolumab vs docetaxel in previously treated NSCLC
Year: 2020
Type: article
Source: Lung Cancer
Authors: M. Lind, S. Gettinger, H. Borghaei, J. Brahmer, L. Chow, M. Burgio, J. De Castro Carpeno, A. Pluzanski, O. Arrieta, O. Aren Frontera, R. Chiari, C. Butts, J. Wojcik-Tomaszewska, B. Coudert, M. Garassino, N. Ready, E. Felip, M. Alonso Garcia, D. Waterhouse, M. Domine, F. Barlesi, S. Antonia, M. Wohlleber, D. Gerber, G. Czyzewicz, D. Spigel, L. Crino, W. Eberhardt, A. Li, S. Marimuthu, E. Vokes
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3003383915